1. Home
  2. OVLY vs OBIO Comparison

OVLY vs OBIO Comparison

Compare OVLY & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

HOLD

Current Price

$34.32

Market Cap

269.7M

Sector

Finance

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.45

Market Cap

246.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
OBIO
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
246.2M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
OVLY
OBIO
Price
$34.32
$4.45
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.25
AVG Volume (30 Days)
24.2K
153.6K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.16%
N/A
EPS Growth
N/A
33.13
EPS
2.88
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.43
P/E Ratio
$12.03
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$23.65
$2.20
52 Week High
$34.96
$5.42

Technical Indicators

Market Signals
Indicator
OVLY
OBIO
Relative Strength Index (RSI) 65.86 53.38
Support Level $32.81 $4.02
Resistance Level N/A $4.76
Average True Range (ATR) 0.59 0.23
MACD 0.20 0.02
Stochastic Oscillator 83.24 72.41

Price Performance

Historical Comparison
OVLY
OBIO

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: